17th Regulatory and Scientific Affairs Conference

25 January 2018

TOP AGENDA TOPICS

  • Availability of medicines – How to prevent and better mitigate shortages
  • Regulatory consequences of Brexit
  • Simplifying variations – update on regulatory optimisation
  • Implementation phase of the EU/USA Mutual Recognition Agreement (MRA) – How to maximize the benefits
  • New ICH quality guidelines under development: Q11 and Q12 – what is new and what impact can be expected?
  • Falsified Medicines – what should the regulatory experts know about practical implementation?
  • How can patients be provided with up to date and relevant information on their medicines?
  • Regulatory challenges for repurposing established medicines
  • From junior to senior regulatory affairs – How to shape the best regulatory team

SPECIAL SESSION: Put your questions to the Regulators. An opportunity to address questions to European Regulators!

VISIT US AT BOOTH 2

Did you know that Amplexor Life Sciences is the only partner you need to deliver global market-specific content? From multi-lingual content creation, to content management to publishing, Amplexor Life Sciences provides end-to-end solutions tailored to your needs. Visit our life sciences experts at the booth 3 to learn more!

VENUE

The Landmark London Hotel 
222 Marylebone Road
London NW1 6JQ, UK